Climate Change Data

Emergent BioSolutions

Climate Impact & Sustainability Data (2020, 2021, 2022, 2023)

Reporting Period: 2020

Environmental Metrics

ESG Focus Areas

  • Access to medicine
  • Community engagement
  • Compliance
  • Corporate governance
  • Diversity, equity, and inclusion
  • Employee engagement

Environmental Achievements

  • Winnipeg site awarded a certificate of environmental impact achievement for three years in a row for their garment recycling program that diverted up to 16,000 pounds of waste annually from the landfill.

Social Achievements

  • Launched a platform to support a portfolio of recognition opportunities, including peer-to-peer kudos, monetary awards, as well as an annual award nomination process.
  • Introduced a one-time Special Ownership Award to recognize employee contributions, with every full-time employee below the senior vice president level receiving a one-time, fully-vested $7,500 stock award.
  • Launched three inaugural Emergent Resource Groups (ERGs) for Black, women, and military veteran employees.
  • Enterprise-wide turnover rate better than the benchmark for the life sciences industry in 2020.
  • Donated 5,214 units (10,428 doses) of NARCAN® Nasal Spray to high schools, colleges, universities, public libraries, YMCAs, and nonprofits.

Governance Achievements

  • Established a special committee on manufacturing and quality oversight, composed of independent directors.
  • Implemented a three-year Quality Enhancement Plan (QEP) to maximize quality performance and minimize quality risk.

Climate Goals & Targets

Environmental Challenges

  • Product contamination incident during COVID-19 vaccine manufacturing resulting in a temporary suspension of manufacturing and FDA inspection.
Mitigation Strategies
  • Initiated an investigation, implemented corrective actions, developed a comprehensive quality enhancement plan, and resumed manufacturing after working with the FDA and J&J.

Supply Chain Management

Responsible Procurement
  • Supplier quality management department oversees a process to ensure that the supplier and the goods and services they provide meet pre-established standards that ensure the safety, quality, and efficacy of our products.
  • Supply or service agreements include code of conduct expectations for the supplier, workers’ rights and safety, confidentiality, and applicable Federal Acquisition Regulations (FAR).

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: SASB, TCFD, UNSDGs

UN Sustainable Development Goals

  • Goal 3
  • Goal 8
  • Goal 9
  • Goal 10
  • Goal 17

Contributions to SDGs outlined in Appendix

Reporting Period: 2021

Environmental Metrics

Total Energy Consumption:4,139,130 kWh/year (Canton facility)

ESG Focus Areas

  • Access to Medicine
  • Governmental Relationships
  • Community Engagement
  • Innovation
  • Compliance
  • Manufacturing and Product Quality
  • Corporate Governance
  • Patient and Drug Safety
  • Diversity, Equity, and Inclusion
  • Scientific Integrity
  • Employee Engagement
  • Supply Chain Management
  • Environmental, Health, and Employee Safety

Environmental Achievements

  • Partnered with Constellation to source Emission Free Energy Credits (EFECs) at Canton, Massachusetts facility, avoiding an estimated 29,333 metric tons of CO2e.

Social Achievements

  • Launched three employee resource groups (Emerging Women, BRAVE, and BOLD).
  • Supplied more than 10 million doses of NARCAN® Nasal Spray.
  • Launched the Reverse the Silence campaign to address the opioid crisis.
  • 61 percent of director-level and above roles filled by female or person of color candidates.
  • 660 new colleagues onboarded through the global ARRIVE Program.

Governance Achievements

  • Established a special committee on manufacturing and quality oversight.
  • Expanded board of directors membership with a new independent director with extensive experience in healthcare compliance.
  • Created and hired a new senior vice president to lead business compliance.

Climate Goals & Targets

Environmental Challenges

  • FDA inspection of Camden facility resulted in a warning letter and reduced operational capacity.
Mitigation Strategies
  • Implemented a Corrective and Preventive Action (CAPA) plan and a detailed site enhancement plan.
  • Hired a CGMP consultant to provide oversight for production.
  • Developed a comprehensive Compliance Action Plan (CAP).

Supply Chain Management

Responsible Procurement
  • Developed a procurement policy aligned with ESG priorities.
  • Supplier diversity program partnering with diverse suppliers.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: TCFD, SASB

UN Sustainable Development Goals

  • Goal 3
  • Goal 8
  • Goal 9
  • Goal 10
  • Goal 17

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:40,434 tCO2e/year
Scope 1 Emissions:19,334 tCO2e/year
Scope 2 Emissions:21,099 tCO2e/year
Total Energy Consumption:69,237 MWh/year
Water Consumption:518,461 m3/year
Carbon Intensity:13.6 tCO2e/employee (2022)

ESG Focus Areas

  • Access to Medicine
  • Governmental Relationships
  • Community Engagement
  • Innovation
  • Compliance
  • Manufacturing and Product Quality
  • Corporate Governance
  • Patient and Drug Safety
  • Diversity, Equity, and Inclusion
  • Scientific Integrity
  • Employee Engagement
  • Supply Chain Management
  • Environmental, Health, and Employee Safety

Environmental Achievements

  • Collected data on Scope 1 and Scope 2 greenhouse gas (GHG) emissions.

Social Achievements

  • Launched three employee resource groups (ERGs) to support women, veterans, and Black/African American colleagues.
  • Delivered 63 instructor-led workshops to 1,100 employees.
  • Donated 13,357 units (26,714 doses) of NARCAN® Nasal Spray.
  • Donated 200 vials of BAT® to Ukraine.

Governance Achievements

  • Appointed a new independent director, Sujata Dayal, to the board of directors.
  • Established a special committee on manufacturing and quality oversight.
  • Created a new senior vice president position to lead the business compliance function.

Climate Goals & Targets

Environmental Challenges

  • U.S. Food and Drug Administration (FDA) issued a warning letter regarding the Camden facility.
Mitigation Strategies
  • Took immediate action to make necessary remediations and improvements at the Camden facility.
  • Provided updates to the FDA.

Supply Chain Management

Responsible Procurement
  • Supplier Quality Management department ensures suppliers meet pre-established standards.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: TCFD, SASB

UN Sustainable Development Goals

  • Goal 3
  • Goal 8
  • Goal 9
  • Goal 10
  • Goal 17

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:35,292 tCO2e/year
Scope 1 Emissions:16,856 tCO2e/year
Scope 2 Emissions:18,436 tCO2e/year
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:59,277 MWh/year
Water Consumption:481,358 m3/year
Waste Generated:Not disclosed
Carbon Intensity:13.9 tCO2e/FTE

ESG Focus Areas

  • Talent Attraction, Engagement, and Development
  • Ethics and Compliance
  • Product Quality and Patient Safety
  • Sustainable Innovation
  • Product Affordability and Accessibility
  • Responsible Supply Chain
  • Clinical Trial Practices
  • Supplier Product Quality, Reliability, and Compliance
  • Diversity, Equity, and Inclusion
  • ESG Oversight
  • Climate Impact
  • Occupational Health and Safety

Environmental Achievements

  • Reduced Scope 1 and 2 emissions by 473 tCO2e at the Lansing, Michigan site through energy conservation measures.

Social Achievements

  • Launched the Ready to Rescue campaign to combat the opioid epidemic, distributing ~5,000 Ready to Rescue kits.
  • Donated 12,396 units (24,792 doses) of NARCAN® Nasal Spray in the U.S.
  • Improved Culture of Quality Index Score by nearly three points over 11 months.

Governance Achievements

  • Received FDA warning letter close-out letter for Camden facility, indicating adequate address of violations.
  • Launched the “I Speak Up” campaign to improve quality and compliance culture.
  • Revamped Code of Conduct and Business Ethics Policy with employee input.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Developing a comprehensive understanding of Scope 3 emissions.
  • Maintaining a strong cybersecurity posture.
  • Navigating change and disruption within the company.
Mitigation Strategies
  • Continuously refining methods to determine Scope 1 and 2 emissions and expanding data collection efforts for Scope 3.
  • Implementing a certified information security program compliant with NIST framework and regulatory requirements.
  • Prioritizing building skills needed to lead, adapt, and thrive during times of change through various programs.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Supplier evaluations based on price, sustainability, financial stability, and government 'do not use' lists.
  • Additional evaluations for GxP compliant suppliers.

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: TCFD, SASB

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Goal 3
  • Goal 8
  • Goal 9
  • Goal 10
  • Goal 17

Initiatives contribute to these goals through various programs and activities detailed in the report.

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed